Back to Search Start Over

Identification and Characterization of an Exonic Duplication in PALB2 in a Man with Synchronous Breast and Prostate Cancer.

Authors :
Bouras A
Lafaye C
Leone M
Kherraf ZE
Martin-Denavit T
Fert-Ferrer S
Calender A
Boutry-Kryza N
Source :
International journal of molecular sciences [Int J Mol Sci] 2022 Jan 08; Vol. 23 (2). Date of Electronic Publication: 2022 Jan 08.
Publication Year :
2022

Abstract

PALB2 (partner and localizer of BRCA2 ), as indicated by its name, is a BRCA2 -interacting protein that plays an important role in homologous recombination (HR) and DNA double-strand break (DSB) repair. While pathogenic variants of PALB2 have been well proven to confer an increased risk of breast cancer, data on its involvement in prostate cancer (PrC) have not been clearly demonstrated. We investigated, using targeted next generation sequencing (NGS), a 59-year-old Caucasian man who developed synchronous breast and prostate cancers. This genetic investigation allowed to identify an intragenic germline heterozygous duplication in PALB2 , implicating intronic repetitive sequences spanning exon 11. This variant was confirmed by multiplex ligation probe amplification (MLPA), and genomic breakpoints have been identified and characterized at the nucleotide level (c.3114-811_3202-1756dup) using an approach based on walking PCR, long range PCR, and Sanger sequencing. RT-PCR using mRNA extracted from lymphocytes and followed by Sanger sequencing revealed a tandem duplication r.3114_3201dup; p.(Gly1068Glufs * 14). This duplication results in the synthesis of a truncated, and most-likely, non-functional protein. These findings expand the phenotypic spectrum of PALB2 variants and may improve the yield of genetic diagnoses in this field.

Details

Language :
English
ISSN :
1422-0067
Volume :
23
Issue :
2
Database :
MEDLINE
Journal :
International journal of molecular sciences
Publication Type :
Report
Accession number :
35054852
Full Text :
https://doi.org/10.3390/ijms23020667